[ad_1]
AbbVie inventory slipped on Friday after the pharma big reported adjusted earnings of $3.66 per share on $14.81 billion in third-quarter gross sales.
X
On common, analysts polled by FactSet anticipated AbbVie (ABBV) to earn $3.57 per share on $14.96 billion in gross sales. The corporate famous “non permanent financial headwinds” hamstrung its aesthetics division, together with Botox face-filler and wrinkle-fighter Juvederm.
Within the year-earlier interval, AbbVie earned $2.83 per share on $14.34 billion in gross sales.
For the 12 months, AbbVie narrowed its earnings outlook to $13.84-$13.88 per share, however saved the identical midpoint. The corporate did not supply gross sales steerage. AbbVie inventory analysts forecasted adjusted revenue of $13.85 per share and $58.92 billion in gross sales.
In premarket buying and selling on at the moment’s inventory market, AbbVie inventory skidded 3.3%, buying and selling close to 148.40.
Extra to observe.
Observe Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Merck Surges Inside Purchase Zone As Two Key Merchandise Drive Its Bullish Report
Why Pandemic Darlings Teladoc, Align Diverged On Their Third-Quarter Experiences
Choices Buying and selling: How To Begin Utilizing Choices, How To Handle Threat
Observe Premarket And After-The-Open Motion With IBD Consultants
Shares To Purchase And Watch: High IPOs, Huge And Small Caps, Development Shares
In the rapidly evolving digital marketing landscape, finding content creators who authentically represent your brand…
Before diving into the specifics, it's important to understand what a demolition contractor does. These…
Hey there! If you're cruising around Arlington and suddenly find your windshield cracked or shattered,…
Hello there! If you're searching for the top asphalt paving companies in Indiana, you're in…
Hey there! If you've ever driven on a smooth, sleek road and thought, "Wow, this…
Hello, enterprising souls of Anaheim! Are you eager to breathe new life into your commercial…
